In the same experiment performed in the presence of 0.1 nM free P-α-synuclein a binding of approximately 80–90% and 70–80% of the maximal binding is obtained for anti-P-α-synuclein NAbs in plasma from PD and MSA patients, respectively. This evidence concerns the gene SNCA and multiple system atrophy.